Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi, UCB enter small-molecule drug development deal for immune-mediated diseases
Sanofi, UCB enter small-molecule drug development deal for immune-mediated diseases
Sanofi, UCB enter small-molecule drug development deal for immune-mediated diseases
Submitted by
admin
on March 11, 2014 - 8:37am
Source:
First Word Pharma
News Tags:
Sanofi
UCB Pharmaceuticals
small molecule drugs
drug development
Headline:
Sanofi, UCB enter small-molecule drug development deal for immune-mediated diseases
Do Not Allow Advertisers to Use My Personal information
